(HealthDay)—In an early trial, an experimental breast cancer drug stopped disease growth and shrank tumors by more than 30 percent in some patients.
Apr 06, 2014
5 / 5 (5) | 0
Johns Hopkins Kimmel Cancer Center investigators report they have designed a blood test that accurately detects the presence of advanced breast cancer and also holds promise for precisely monitoring response to cancer treatment.
Apr 15, 2014
5 / 5 (2) | 0